MiMedx Group Inc. (MDXG) - NASDAQ
  • Mon, Jan. 11, 9:55 AM
    • MiMedx Group (MDXG +3.4%) acquires privately held Stability, Inc., doing business as Stability Biologics, for $10M in cash and stock plus assumed debt. The Nashville, TN-based firm provides human tissue products that are used in surgical, spine and orthopedic procedures.
    • The company expects the transaction to be accretive to non-GAAP EPS this year and contribute $15M to revenues. The deal should close in by mid-month.
    • MiMedx updated 2016 guidance: revenues: $260M - 270M; non-GAAP EPS: $0.33 - 0.37.
    • Q1 guidance: revenues: $55.5M - 58.0M.
    | Mon, Jan. 11, 9:55 AM
Company Description
MiMedx Group, Inc. is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. Its biomaterial platform technologies include AmnioFix and EpiFix, its tissue technologies processed from human... More
Sector: Healthcare
Industry: Medical Appliances & Equipment
Country: United States